← Back to patent-cliff list
胆骨化醇/利塞膦酸钠
Tier C — Watch / tradeColecalciferol/Risedronate Sodium
韩美药品株式会社
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：VDR、FDPS
Brand：Risenex plus、Risen Plus、Ridrone Plus、Risenex M
Indications (approved)：骨质疏松症
Regional status
US
-
EU
-
China
临床一期
2016-06-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Colecalciferol/Risedronate Sodium?
Approved indications include: 骨质疏松症.
When does the Colecalciferol/Risedronate Sodium patent expire?
No public expiry year is available for Colecalciferol/Risedronate Sodium yet; this page updates once verified.
How do I get a quote for Colecalciferol/Risedronate Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24